Home > Information
Information
- Jan. 15, 2024
- Result of a Japan-led International Investigator-Initiated Registration-Directed Trial Offers a New Treatment Option of Palbociclib in Combination with Tamoxifen
- Jan. 11, 2024
- An Asian Multicenter Clinical Trial Evaluating Efficacy of
Computer-Aided Detection for Colonoscopy in Colorectal Cancer Screening - Dec. 1, 2023
- Sharing of clinical trial information improves the quality of treatment recommendations by expert panels
- Sep. 22, 2023
- Introduction video of THE NATIONAL CANCER CENTER HOSPITAL JAPAN has been released
- Aug. 29, 2023
- Invitation to 8th Annual MASTER KEY Project Online Information Session
- Jun. 27, 2023
- Memorandum of Cooperation on Decentralized Clinical Trials between the Department of Medical Services and the National Cancer Center Japan.
- Apr. 10, 2023
- Efficacy of Anti-HER2 Therapy with Trastuzumab Deluxecan in Uterine Carcinosarcoma Consistent with PDX-model predictions of efficacy, paving the way for the development of treatments for rare cancers.
- Apr. 3, 2023
- A clinical trial of Tazemetostat for pediatric and AYA patients with malignant tumors which have no standard treatment or which is refractory to standard treatment using Patient-Proposed Healthcare Service (NCCH2214/ TURTLE trial) to improve drug access for pediatric and AYA patients with refractory tumors.
- Feb. 20, 2023
- NCC Announces Positive Top-Line Results of Japan-led international Investigator-Initiated Registration-Directed Phase III Study Evaluating Palbociclib Plus Tamoxifen in Patients with Hormone Receptor-positive, HER2-negative Advanced or Metastatic Breast Cancer (NCCH1607/PATHWAY trial)
- Dec. 8, 2022
- Asian multicenter prospective study (CHOICE study) to elucidate the pathogenesis of cholangiocarcinoma(including FGFR2-rearranged) launched
- Nov. 2, 2022
- Yusuke Okuma has been awarded “Best of the AACR Journals”
- Oct. 20, 2022
- National Cancer Center Hospital on Newsweek’s “World’s Best Specialized Hospitals 2023 (Oncology)”
- Aug. 24, 2022
- Large scale clinical trial for Neuroendocrine Carcinoma (NEC), a rare and refractory cancer establishes current chemotherapy for advanced and recurrent cancer as standard therapy
- Aug. 5, 2022
- Prospective Cohort Study demonstrates ESD as primary choice of treatment for neoplasia of over 2cm
- Aug. 1, 2022
- Supporting Cancer Registration in Viet Nam
- Jul. 1, 2022
- Utility of gene panel testing for comprehensive genomic profiling of blood cancers demonstrated
- May 25, 2022
- Cooperation with the U.S. National Cancer Institute welcomed by Japan-US leaders in joint statement- role of National Cancer Center highlighted
- Mar. 18, 2022
- Aberrant activation of cell cycle-related kinases in uterine leiomyosarcoma
- Feb. 1, 2022
- Virtual Meeting with Tata Memorial Centre of India, Celebrating the Conclusion of Memorandum of Understanding
- Jan. 28, 2022
- Virtual Meeting with Gansu Provincial Cancer Hospital in China
- Dec. 23, 2021
- Launch of an Asian international collaborative prospective study on 6 advanced cancers common in Asia
- Dec. 14, 2021
- Endoscopists at the National Cancer Center Hospital selected as world-class experts in endoscopic mucosal resection (EMR) by Expertscape
- Oct. 20, 2021
- MASTER KEY ASIA
- Oct. 7, 2021
- National Cancer Center Hospital on Newsweek’s “World’s Best Specialized Hospitals 2022 (Oncology)”
- Sep. 13, 2021
- Webinar on Clinical Research with Guangxi, China
- Sep. 8, 2021
- Shun-ichi Watanabe awarded the Ginsberg Lectureship Award for Surgery at the 2021 World Conference on Lung Cancer
- Jun. 2, 2021
- SARS-CoV-2 antibody status in patients with cancer during the COVID-19 pandemic in Japan
- May 14, 2021
- NATIONAL CANCER CENTER AND EISAI COMMENCE JOINT RESEARCH AND DEVELOPMENT PROJECT “BASIC RESEARCH ON THE DRUG DISCOVERY AND DEVELOPMENT TO ACCELERATE DEVELOPMENT OF ANTICANCER DRUGS IN TREATMENT OF PATIENTS WITH RARE CANCERS AND REFRACTORY CANCERS”, USING PDX WITH HIGH PREDICTABILITY OF CLINICAL OUTCOMES, AND CANCER GENOME DATA
- Mar. 23, 2021
- First drug approved for unresectable thymic carcinoma
- Feb. 5, 2021
- Endoscopy Lectures on the web
- Nov. 19, 2020
- MOU signed with Clinical Research Malaysia (CRM)
- Oct. 19, 2020
- National Cancer Center Hospital on Newsweek’s “World’s Best Specialized Hospitals 2021 (Oncology)”
- Sep. 17, 2020
- The Endoscopy Center Sharing Expertise Overseas
- Sep. 9, 2020
- Asian early phase drug development network
ATLAS Project – Paving the way towards developing drugs with Asian partners - Aug. 20, 2020
- NCC joins GSK’s oncology development network
- Mar. 2, 2020
- HE Professor Tomasz Grodzki, Polish Senate Marshal visit
- Feb. 21, 2020
- To contain the spread of new coronavirus, the National Cancer Center of Japan requests your kind cooperation for the welfare of our patients
- Jan. 29, 2020
- Clinical Trial Investigators visit NCC Hospital
- Dec. 11, 2019
- Test Result of New Antiemetic Therapy for Chemotherapy-induced Nausea and Vomiting Proves Higher Efficacy Than Standard Antiemetic Therapy
- Nov. 7, 2019
- Commencement of Clinical Trial of Boron Neutron Capture Therapy (BNCT) for Malignant Melanoma and Angiosarcoma
- Oct. 10, 2019
- NCC colorectal Surgeons visit Sakha Republic, Russia
- May 29, 2019
- Cancer Gene Panel Test OncoGuideTM NCC Oncopanel System added to Health Insurance Coverage list
- Mar. 7, 2019
- Kazakhstan Delegation visit
- Jan. 22, 2019
- Dr Kazuaki Shimada appointed Honorary Professor at Tianjin Medical University Cancer Institute and Hospital
- Nov. 19, 2018
- Action across borders
- Nov. 12, 2018
- Facilitating International Clinical Trials Initiated by
Japanese Academic Institutions
Japan-led Global Investigator-Initiated Registration-Directed Trial of Advanced or Metastatic Breast Cancer (PATHWAY trial) Has Started - Apr. 3, 2018
- National Cancer Center Hospital offers Next Generation Sequencing tests as ‘Advanced Medical Care’
Towards coverage under national health insurance system - Apr. 3, 2018
- Advanced Medical Care Approval Received for Multiplex Gene Panel Testing
to Advancing Personalized Medicine - Feb. 5, 2018
- Maestro Chung Visit
- Aug. 1, 2017
- On-Table Adaptive Radiation Therapy
- Jul. 31, 2017
- The MASTER KEY PROJECT
Genomic medicine in Rare Cancers:
A collaboration between the industry and academia